TABLE 5.
Test method (name) | blaOXA-48-like genes detected | Other genes detected | Reference |
---|---|---|---|
Real-time multiplex PCR, molecular beacon probe (Check-Direct CPE; Checkpoints, Wageningen, the Netherlands) | blaOXA-48, blaOXA-162, blaOXA-163, blaOXA-181, blaOXA-204, blaOXA-232, blaOXA-244, blaOXA-245, and blaOXA -370 | blaKPC, blaNDM, and blaVIM (blaKPC/blaNDM signal cannot be differentiated) | 292 |
Real-time multiplex PCR (EntericBio CPE; Serosep Limited, Limerick, Ireland) | Yes | blaKPC, blaGES, blaNDM, blaVIM, and blaIMP | 293 |
Real-time multiplex PCR, hydrolysis probe (Amplidiag CarbaR+VRE; Mobidiag Limited, Espoo, Finland) | blaOXA-48, blaOXA-162, blaOXA-181, blaOXA-204, blaOXA-232, and blaOXA-244 | blaKPC, blaNDM, blaVIM, blaIMP, ISAba1-blaOXA-51, blaOXA-23, 24/40, -58, vanA, and vanB | 294 |
Real-time multiplex PCR, hydrolysis probe (Amplidiag CarbaR+MCR; Mobidiag Limited, Espoo, Finland) | blaOXA-48, blaOXA-162, blaOXA-181, blaOXA-204, blaOXA-232, and blaOXA-244 | blaKPC, blaGES, blaNDM, blaVIM, blaIMP, ISAba1-blaOXA-51, blaOXA-23, blaOXA24/40, blaOXA-58, and mcr | 295 |
Conventional PCR, DNA hybridization (AID carbapenemase line probe assay; Autoimmun Diagnostika GmbH, Strassberg, Germany) |
Yes | blaKPC, blaIMI, blaNCM-A, blaNDM, blaVIM, blaIMP, blaSPM, blaBIC, blaAIM, blaGIM, blaSIM, and blaDIM | 223 |
LAMP, Genie II platform (eazyplex SuperBug CRE; Amplex, Giessen, Germany) | blaOXA-48, blaOXA-162, blaOXA-204, and blaOXA-244; blaOXA-181 and blaOXA-232a | blaKPC, blaNDM, blaVIM, blaCTX-M-1 group, and blaKCTX-M-9 group | 297 |
Microarray (Check-MDR CT103 XL; Checkpoints, Wageningen, the Netherlands) | blaOXA-48, blaOXA-162, blaOXA-163, blaOXA-181, blaOXA-204, blaOXA-232, blaOXA-244, blaOXA-245, and blaOXA-370 | blaKPC, blaGES, blaNDM, blaVIM, blaIMP, blaSPM, blaGIM, blaOXA-23-like, blaOXA-24-like, blaOXA-58-like genes, ESBLs, and AmpCs | 236 |
These groups were separately detected in different tubes according to the manufacturer. The initial assay could not detect blaOXA-181.